David Zebrowski PhD

David C. Zebrowski, PhD, is the Founder and CEO of GenKardia, an early-stage biotechnology company developing novel therapies for heart failure. A seasoned leader in cardiovascular research, he previously served as a tenure-track Assistant Professor at The Chinese University of Hong Kong, where his lab focused on molecular cardiology and cardiac regeneration. Dr. Zebrowski also brings industry experience from his role as a Heart Failure Specialist and member of the Cardiovascular Leadership Team at Novo Nordisk. He currently serves as an Expert Advisor for Nucleate New York, supporting the next generation of biotech innovators.